Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmacor is a leading Australian pharmaceutical company specializing in the development, marketing, and distribution of high-quality generic medicines. As a subsidiary of the global pharmaceutical giant Hetero Labs, Pharmacor leverages extensive vertical integration to provide a broad portfolio of prescription and over-the-counter products across various therapeutic areas, including cardiology, endocrinology, and neurology. The company focuses on improving healthcare accessibility by offering cost-effective alternatives to brand-name medications while maintaining rigorous quality standards. Pharmacor's operations are supported by a robust supply chain and a commitment to meeting the specific needs of the Australian healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmacor.